GUIDE TO THE EVALUATION OF COMMUTABILITY OF CONTROL MATERIALS

Similar documents
Commutability studies undertaken by the LNE : the case of lipid and lipoprotein testing. Vincent Delatour, PhD

METHOD VALIDATION: WHY, HOW AND WHEN?

Towards a Certified Reference Material for HbA 2

liquicolor (AMP Buffer, IFCC) Design Verification

Bias in clinical chemistry. Elvar Theodorsson EFLM and Linköping University

Agenda. 15 Dec

liquicolor Design Verification

LIPASE liquicolor. Design Verification. Multipurpose Reagent

Keywords: albuminuria; albumin/creatinine ratio (ACR); measurements. Introduction

Harmonization of Clinical Laboratory Results is Essential for Quality Patient Care

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)

METHOD VALIDATION CASE

Toward Standardization of Insulin Immunoassays

Week 17 and 21 Comparing two assays and Measurement of Uncertainty Explain tools used to compare the performance of two assays, including

Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on. CUBE analyser (CA0100)

Farouk AL Quadan lecture 3 Implentation of

BIOLOGICAL VARIABILITY: THE CIRME CONTRIBUTION. F. Braga Centre for Metrological Traceability in Laboratory Medicine (CIRME)

Glucose Analytical Comparability Evaluation of the YSI 2300 STAT Plus and YSI 2900D Biochemistry Analyzers

Guide to Fulfillment of Measurement Uncertainty

IFCC Scientific Division Report to Council, Istanbul, June Ian S.Young Queen s University Belfast Chair, IFCC-SD

Analytical performance specifications two years after Milan conference. Prof Mauro Panteghini CIRME Scientific Coordinator

METHOD VALIDATION CASE

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

Method Comparison Report Semi-Annual 1/5/2018

CoQ10(Coenzyme Q10) ELISA Kit

General Chemistry Scheme Guide

Performance Guide. icheck Iodine The test kit to measure iodine in salt

Performance Guide. icheck Chroma 3 The test kit to measure vitamin A in oil

Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

Standardization efforts for Alzheimer CSF biomarkers, and Plasma neurofilament light (NFL) as a biomarker for AD

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

Performance Characteristics of a New Single-Sample Freezing Point Depression Osmometer

Withdrawn at December 31, Guideline DKD-R 6-2. Calibration of Measuring Devices for Vacuum DEUTSCHER KALIBRIERDIENST. Part 1.

1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)

G. Snodgrass, K. Ackles, A. Blanco and A. Versaggi Ortho Clinical Diagnostics, Rochester, NY 14626

A Method for Statistical Process Control of Radiation Sterilization Facilities

1. PROTOCOL. Comparison Study Summary. Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR July 30, 2014

Traceability in External Quality Assessment: How Weqas ensures traceability in EQA and stresses its importance to users. David Ducroq.

CCQM-K6: Key Comparison on the Determination of Cholesterol In Serum* Final Report December 2001

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

External quality assessment schemes in Latin America

Standardization of. S.M.Boutorabi DCLS,PhD

CDC s Clinical Standardization Programs

White Paper, Evaluation of WaveSense JAZZ Blood Glucose Monitoring System Analytical Performance to EN ISO 15197:2015 Standard

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

INTERNAL QUALITY CONTROL ( Q I C) QC)

Validation Case studies: the good, the bad and the molecular

Should HbA1C measured by POC instruments be used for diagnosis of diabetes? Sverre Sandberg, Norwegian Quality Improvement of Primary Care

Selecting a Risk-Based SQC Procedure for a HbA1c Total QC Plan

ISPM No. 28 PHYTOSANITARY TREATMENTS FOR REGULATED PESTS (2007)

Why Traceability Matters to Patients?

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

Serodos and Serodos plus

Cortisol Assays. The Good, The Bad and The Indifferent. David Ducroq. Cardiff and Vale ulhb WEQAS. Unit 6, Parc Tŷ Glas. Llanishen.

Simple Linear Regression the model, estimation and testing

Choosing a Significance Test. Student Resource Sheet

Certified Reference Materials - A Path to Traceable Chemical Measurements

Validity and Reliability of a Glucometer Against Industry Reference Standards

What I will talk about

A PROPOSED REFERENCE MATERIAL FOR OXIDATIVE INDUCTION TIME BY DIFFERENTIAL SCANNING CALORIMETRY

ORIGINAL ARTICLE. Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

IDEXX Catalyst One Chemistry Analyzer for In-house Measurement of Total Thyroxine (TT 4 ) Concentration in Serum from Dogs and Cats

SCIEX Vitamin D 200M Assay for the Topaz System

Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System

Laboratory Medicine Standardization Activity in Japan

CRITERIA FOR USE. A GRAPHICAL EXPLANATION OF BI-VARIATE (2 VARIABLE) REGRESSION ANALYSISSys

Design Verification IMTEC-TSH R -A C Intended Use... 2 Diagnostic Sensitivity and Diagnostic Specificity... 2 Interferences... 4 Imprecision...

Calibration of High-Density Lipoprotein Cholesterol Values From the Korea National Health and Nutrition Examination Survey Data, 2008 to 2015

10 Intraclass Correlations under the Mixed Factorial Design

ANOVA in SPSS (Practical)

EVALUATING THE UNCERTAINTY OF MEASUREMENT ON BLOOD'S GLUCOSE LEVEL

Official Journal of the European Union L 109/11

Commutability of Calibration and Control Materials for Serum Lipase

1.4 - Linear Regression and MS Excel

Dr Bill Bartlett Blood Sciences, Ninewells Hospital & Medical School, NHS Tayside, Scotland, UK.

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome

CCQM-K63.a,b. Non-Peptide Hormones in Serum: Cortisol and Progesterone. Final Report: 20-Jan-2010

Received: June 06, 2016 Accepted: September 10, /bm Biochem Med (Zagreb) 2017;27(3):

1 PROTOCOL. Comparison Study Summary

Chapter 2. High-sensitivity C-reactive protein methods examined

TSH Receptor Autoantibody ELISA

Dubrovnik 2014 Sverre Sandberg, Norwegian Quality Improvement of Primary Care Laboratories Noklus, Bergen, Norway

Mike Hinds, Royal Canadian Mint

A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls

ISO INTERNATIONAL STANDARD

Special issue: External Quality Assessment in Laboratory Medicine Review

Addressing error in laboratory biomarker studies

Human Neurology 3-Plex A

LAS-Q008. Proficiency Testing Requirements for Testing and Calibration Laboratories

Evaluation of the analytical performances of six measurands for thyroid functions of Mindray CL-2000i system

Steps to writing a lab report on: factors affecting enzyme activity

Human Alpha 1 microglobulin ELISA Kit

Global Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488

What information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani

IFCC Working Group on Standardization of Thyroid Function Tests (WG-STFT) Meeting at AACC 2008, Washington DC, Monday July 28 (2:00-5:00 pm)

WDHS Curriculum Map Probability and Statistics. What is Statistics and how does it relate to you?

Clinical Chemistry 54: (2008)

ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations

Practical Aspects of Standardisation for a Global Controls Manufacturer

Transcription:

GUIDE TO THE EVALUATION OF COMMUTABILITY OF CONTROL MATERIALS Ferruccio Ceriotti Servizio di Medicina di Laboratorio, Ospedale San Raffaele, Milano

F. Ceriotti, Milano, 27-11-2015 2 Preamble Most of the considerations and the data presented hereafter derive from the work of the IFCC Working Group on Commutability (WG-C) Coordinated by Greg Miller The statistical work was performed by Göran Nilsson

F. Ceriotti, Milano, 27-11-2015 3 5.15 commutability of a reference material Property of a reference material, demonstrated by the closeness of agreement between the relation among the measurement results for a stated quantity in this material, obtained according to two given measurement procedures, and the relation obtained among the measurement results for other specified materials. NOTE 1 The reference material in question is usually a calibrator and the other specified materials are usually routine samples. NOTE 2 The measurement procedures referred to in the definition are the one preceding and the one following the reference material (calibrator) in question in a calibration hierarchy (see ISO 17511).

F. Ceriotti, Milano, 27-11-2015 4 Commutability According to the definition, commutability concerns two measurement procedures. In laboratory medicine there are usually more than two measurement procedures for a measurand; consequently commutability needs to be assessed pair wise for all measurement procedures for which a RM is intended to be used. Commutability depends upon material method interaction Non-commutability is an undesired byproduct of materials preparation combined with the specificity limitations of some clinical laboratory methods.

Consequences of noncommutability Introduction of a BIAS 1. In the calibration process: - break in the traceability chain F. Ceriotti, Milano, 27-11-2015 5 2. In EQA schemes: - non reliable inter-method variability evaluation - non feasibility of target value assignment based on Reference measurement procedure

F. Ceriotti, Milano, 27-11-2015 6 Assessment of commutability Assessment of commutability requires the following steps: Obtain representative clinical samples (CSs) Obtain RM(s) to be evaluated Measure the CSs and RM(s) with the measurement procedures for which the RM(s) are intended to be used Determine the difference between the measurement procedure results for the RM(s) and the CSs Determine if this difference is acceptable for the intended use of the RM(s)

F. Ceriotti, Milano, 27-11-2015 7 1. Selecting clinical samples for inclusion in a commutability assessment The interval of quantities (e.g. concentrations) of the measurand in the CSs must include that of the RM(s). The interval of quantities must be within the dynamic range of both methods Clinical samples should be selected with consideration of measurement procedure selectivity limitations a commutability assessment is not intended to evaluate the selectivity of measurement procedures for the measurand; qualification of measurement procedures to be included in a commutability study should be done in advance.

F. Ceriotti, Milano, 27-11-2015 8 1. Selecting clinical samples for inclusion in a commutability assessment (2) Individual CSs are preferred for a commutability assessment. Pooling may affect commutability and represents a potential limitation, but volume limitations for difficult to obtain samples may require pooling; If pools are used, a validation scheme to demonstrate commutability of a pool based on recovery of a value expected from the proportion of each donor sample used to prepare the pool should be performed (CLSI C37-A). Clinical samples must be collected, and aliquots prepared, stored and distributed such that no alteration of the measurand or matrix occurs. Freezing or other storage may affect commutability and should be evaluated for suitability in a preliminary experiment.

2. Qualification of measurement procedures for inclusion in a commutability assessment It is desirable to include as many different analytical measurement principles as possible Measurement procedures must have acceptable performance characteristics to be included in a commutability assessment. adequate precision, because an excessively large SD can inappropriately influence assessment of commutability adequate selectivity for the measurand F. Ceriotti, Milano, 27-11-2015 9 residual around the relationship should be comparable with that of the other candidate measurement procedures. linear relationship with other measurement procedures

Possible approaches to assess commutability F. Ceriotti, Milano, 27-11-2015 10 1. Regression approach 2. Based on the difference in bias between a RM and CSs 3. Effectiveness of a RM used as a calibrator to improve harmonization among results from different measurement procedures

Regression approach F. Ceriotti, Milano, 27-11-2015 11

F. Ceriotti, Milano, 27-11-2015 12 Regression approach: statistical design A linear relationship between measurement procedure A and B is assumed. The relationship between the results obtained with these two measurement procedures on n native clinical samples can be expressed by the equation: y = a + bx A 95% prediction interval around the line described by the equation can be calculated. Commutability of a RM is assumed when its Y R, X R point falls inside the prediction interval

F. Ceriotti, Milano, 27-11-2015 13 Regression approach: experimental design Select at least 20 clinical samples (CSs), Analyze them in triplicate in a single run with both methods together with the RM also in triplicate. Calculate the regression equation according to Deming and the 95% prediction interval using only the CSs data. Plot the data on a graph and verify if the RM falls inside the prediction interval [alternatively, instead of an x y plot a bias plot can be used]

F. Ceriotti, Milano, 27-11-2015 14 AST: method comparison (x-y plot)

AST: method comparison (bias plot) 10 F. Ceriotti, Milano, 27-11-2015 15 Modular - Ref. Met (U/L) 5 0-5 Sera RM -10 0 50 100 150 200 250 Reference method (U/L)

F. Ceriotti, Milano, 27-11-2015 16 Regression approach Limits: using a prediction interval for assessment of commutability is a test of the hypothesis that the RM can be considered to belong to the same population as the CSs. Not rejecting a hypothesis does not prove that it is true The prediction interval approach does not quantify how closely the RM agrees with the average relationship for the CSs at the concentration of interest.

Possible approaches to assess commutability F. Ceriotti, Milano, 27-11-2015 17 1. Regression approach 2. Based on the difference in bias between a RM and CSs 3. Effectiveness of a RM used as a calibrator to improve harmonization among results from different measurement procedures

F. Ceriotti, Milano, 27-11-2015 18 Difference in bias between a RM and CSs: statistical design Commutability of the RM concerns how close the systematic difference between the measurement procedures (the bias) for the RM is to the average bias for the CSs, at the concentration of the RM. The difference between the bias for the RM and the average bias for the CSs (D RM ) expresses the closeness of agreement between the bias for the RM and the bias for the CSs. For the assessment of commutability we need to specify a maximum value of D RM for the RM to be considered as commutable (commutability criterion = C).

F. Ceriotti, Milano, 27-11-2015 19 Difference in bias between a RM and CSs: statistical design 1. The uncertainty interval D RM ± U(D RM ) is within 0 ± C: the RM is commutable. 2. The uncertainty interval D RM ± U(D RM ) is outside 0 ± C: the RM is non-commutable. 3. The uncertainty interval D RM ± U(D RM ) and 0 ± C are overlapping: the result is inconclusive. An inconclusive result can be caused by: A too stringent commutability criterion. A too large uncertainty. When U(D RM ) > C it will obviously not be possible to verify commutability. The experimental design of a commutability assessment must give a sufficiently small value of U(D RM ).

F. Ceriotti, Milano, 27-11-2015 20 Difference in bias between a RM and CSs: Experimental design n CSs, evenly distributed in the interval that includes the concentration of the RM CSs and the RM are measured in three replicates, in one run, with both of the measurement procedures. The RM is measured in triplicates in p different positions in the run. The example in the figure includes 50 CSs and 5 RMs, each one measured 5 times in triplicate

Calculations F. Ceriotti, Milano, 27-11-2015 21

F. Ceriotti, Milano, 27-11-2015 22

Possible approaches to assess commutability F. Ceriotti, Milano, 27-11-2015 23 1. Regression approach 2. Based on the difference in bias between a RM and CSs 3. Effectiveness of a RM used as a calibrator to improve harmonization among results from different measurement procedures

F. Ceriotti, Milano, 27-11-2015 24 Effectiveness of a RM used as a calibrator to improve harmonization among results from different measurement procedures: statistical design If a reference material is commutable, its use as a calibrator will allow different methods to produce comparable results on clinical samples. The commutability is assumed if the MP to MP clinical sample result variability is reduced to a specified limit (e.g. CV 3%). In addition there may be requirements for EQA/PT variability (e.g. CV 5%). It is necessary to identify if an MP or individual samples need to be excluded from the set of clinical samples and MPs to be used in the RM commutability assessment.

Effectiveness of a RM used as a calibrator to improve harmonization among results from different measurement procedures: experimental design Use the RM as calibrator in a reference measurement procedure and in all the measurement procedures in which is requested to test its commutability. Measure 40 CSs in triplicate F. Ceriotti, Milano, 27-11-2015 25 Calculate the average of the inter method CV estimates, Inter Measurement Procedure CV (IMPCV), and compare to the predetermined variability requirements. Inspect the data to verify if some sample or some MP has peculiar behavior and eventually discard them and recalculate the CV

F. Ceriotti, Milano, 27-11-2015 26 Example Higher CVH IMPCV

Example Negative bias F. Ceriotti, Milano, 27-11-2015 27 Variablity of the residuals

Example F. Ceriotti, Milano, 27-11-2015 28

F. Ceriotti, Milano, 27-11-2015 29 Limits Better applicable to RM intended to be used as calibrators Assumes a calibration function with no intercept Requires multiple methods (but this is usually the case) Statistical requirements not yet defined in detail, especially regarding how to perform calibration.

F. Ceriotti, Milano, 27-11-2015 30 The ratio method to confirm commutability of a new batch of commutable RM Rationale: if a first batch of RM is assessed and demonstrated to be commutable, the following batches, provided that are manufactured according to the same process, do not need a new extensive evaluation of commutability, but commutability can be confirmed with a simpler method. Experimental design: the new and old RM batches are measured with N replicates with the relevant measurement procedures (MP) including a reference MP (if available) in the same analytical run for each MP. The ratio (mean from new batch)/(mean from old batch) is calculated for each MP. When ratios for the respective MPs fall within the pre-established range, it is concluded that the new batch of RM has the same commutability properties as the old batch.

F. Ceriotti, Milano, 27-11-2015 31 Conclusions All the presented approaches require a large number of measurements to reach an high statistical power (low uncertainty), so their applicability to large commutability studies is questionable. The use of simplified designs based on a small number of pools in place of individual CSs and has still to be evaluated and validated. The ratio method is still under statistical evaluation, but appears a valid solution for commutability confirmation and maybe not only for confirmation.

F. Ceriotti, Milano, 27-11-2015 32 Thanks for your attention!